SVFAX
Price
$79.58
Change
+$0.16 (+0.20%)
Updated
Aug 15 closing price
Net Assets
4.55B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

SVFAX vs VVIAX

Header iconSVFAX vs VVIAX Comparison
Open Charts SVFAX vs VVIAXBanner chart's image
Smead Value A
Price$79.58
Change+$0.16 (+0.20%)
VolumeN/A
Net Assets4.55B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
SVFAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SVFAX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVFAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. SVFAX (4.55B). VVIAX pays higher dividends than SVFAX: VVIAX (2.18) vs SVFAX (1.19). SVFAX was incepted earlier than VVIAX: SVFAX (12 years) vs VVIAX (25 years). SVFAX (1.22) is less costly to investors than VVIAX (0.05). SVFAX is a more actively managed with annual turnover of: 13.30 vs. VVIAX (9.00). SVFAX (3000) and VVIAX (3000) have matching initial minimum investment requirements. VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. SVFAX (-1.55). SVFAX return over 5 years is better than : 81.24 vs. VVIAX (68.54).
SVFAXVVIAXSVFAX / VVIAX
Total Expense Ratio1.220.052,440%
Annual Report Gross Expense Ratio1.220.052,440%
Fund Existence12 years25 years-
Gain YTD1.6486.51725%
Front Load6%N/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.55B196B2%
Annual Yield % from dividends1.192.1855%
Returns for 1 year-1.557.91-20%
Returns for 3 years23.0825.9389%
Returns for 5 years81.2468.54119%
Returns for 10 years103.53114.6190%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp